5-HT.sub.1F agonists for the treatment of migraine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514318, 546193, 546201, A61K 31445, C07D40104

Patent

active

055211968

ABSTRACT:
This invention provides novel 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders.

REFERENCES:
patent: 3850938 (1974-11-01), Derible et al.
patent: 4359468 (1982-11-01), Freter et al.
patent: 4530932 (1985-07-01), Clemence et al.
patent: 4710500 (1987-12-01), Perregaard
patent: 4742057 (1988-05-01), Ueda et al.
patent: 4997841 (1991-03-01), Oxford et al.
patent: 5001135 (1991-03-01), Oxford et al.
patent: 5017703 (1991-05-01), Matsuo et al.
patent: 5036078 (1991-07-01), Coates
patent: 5045550 (1991-09-01), Jaen
patent: 5066660 (1991-11-01), Oxford et al.
patent: 5118691 (1992-06-01), Jaen et al.
patent: 5187280 (1993-02-01), Jaen et al.
patent: 5216001 (1993-06-01), Perregaard
patent: 5298520 (1994-03-01), Baker et al.
patent: 5317025 (1994-05-01), BruzMagniez
patent: 5322851 (1994-06-01), Perregaard
Tacconi et al. "Indole derivatives" CA 63:13193e (1965).
Wyngaarden et al. "Cecil Textbook of Medicine" Sauders Co., (1983) pp. 1940-1942.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-HT.sub.1F agonists for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-HT.sub.1F agonists for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT.sub.1F agonists for the treatment of migraine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-787161

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.